NCT05963867 A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer Status RECRUITING Phase PHASE1
NCT05963646 Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study Status COMPLETED Phase N/A
NCT05957198 Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease Status COMPLETED Phase N/A
NCT05945888 A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood Status COMPLETED Phase PHASE1
NCT05934955 A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003) Status COMPLETED Phase PHASE1
NCT05934942 A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Status TERMINATED Phase PHASE1
NCT05916313 A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3 Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05896384 A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood Status COMPLETED Phase PHASE1
NCT05891275 Patients With Geographic Atrophy and Their Patient Journey in the United States (US) Status COMPLETED Phase N/A
NCT05882071 Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05882058 DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers Status RECRUITING Phase PHASE2
NCT05879991 A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body Status COMPLETED Phase PHASE1
NCT05879978 A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05875532 Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment Status COMPLETED Phase N/A
NCT05870956 Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients Status COMPLETED Phase N/A
NCT05865886 A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™) Status COMPLETED Phase PHASE2
NCT05863130 A Study in Healthy Men to Test How BI 764198 is Processed in the Body Status COMPLETED Phase PHASE1
NCT05857878 A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men Status COMPLETED Phase PHASE1
NCT05856526 A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome Status TERMINATED Phase PHASE2/PHASE3